Editorial Board About Us

Benign prostatic hyperplasia

All articles from this key word are listed below.

Volume 5, Supplement 4 Supplement

Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia

Benign prostatic hyperplasia Lower urinary tract symptoms Acute urinary

Volume 5, Supplement 4 Supplement

The Medical Therapy of Prostatic Symptoms Study: What Will We Learn?

Benign prostatic hyperplasia Bladder outlet obstruction Benign prostatic

Volume 5, Number 3 Meeting Reviews

Best of the 2003 AUA Annual Meeting

Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003

Kazumasa Torimoto Matthew B Gretzer Michael Dobrovits Mesut Remzi Allan J Pantuck Arie S Belldegrun Bob Djavan Dean G Assimos Randall B Meacham Michael K Brawer Claus G Roehrborn Jacob Rajfer J Curtis Nickel Michael B Chancellor Alan W Partin Ellen Shapiro

Prostate cancer Renal cell carcinoma Benign prostatic hyperplasia Depression Bladder cancer Lower urinary tract symptoms Urinary tract infection Prostate-specific antigen Nephrolithiasis Overactive bladder Radical prostatectomy Peyronie’s disease Gleason score Transrectal ultrasound Erectile dysfunction Chronic prostatitis/chronic pelvic pain syndrome Acute urinary retention International Prostate Symptom Score Bacille Calmette-Guérin therapy Chronic Prostatitis Symptom Index MTOPS trial PLESS study Prostate tumor markers SELDI-TOF

Volume 5, Number 2 Review Articles

Quality of Life and Sexual Function in Patients with Benign Prostatic Hyperplasia

Treatment Update

Reginald C Bruskewitz

Benign prostatic hyperplasia Lower urinary tract symptoms Quality of life Erectile dysfunction Sexual dysfunction

Volume 6, Supplement 9 Supplement

AUA Guidelines and Their Impact on the Management of BPH: An Update

Steven A Kaplan

Benign prostatic hyperplasia Medical treatment Guidelines American Urological Association Symptom score

Volume 6, Supplement 9 Supplement

The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy

Kevin M Slawin Michael W Kattan

Benign prostatic hyperplasia Nomogram 5-reductase inhibitors Progression

Volume 6, Supplement 9 Supplement

Comparison of Clinical Trials With Finasteride and Dutasteride

J Curtis Nickel

Benign prostatic hyperplasia Medical therapy Finasteride Dutasteride Dihydrotestosterone 5-reductase

Volume 6, Supplement 9 Supplement

5-Alpha-Reductase: History and Clinical Importance

Leonard S Marks

Benign prostatic hyperplasia Finasteride Dutasteride Dihydrotestosterone 5-reductase Guevedoces

Volume 6, Supplement 9 Supplement

The Clinical Benefits of Dutasteride Treatment for LUTS and BPH

Claus G Roehrborn

Benign prostatic hyperplasia Lower urinary tract symptoms 5-reductase inhibitors Dutasteride Clinical trials